Published Abstracts

• Study of Quantitative Gallium Lung Scans in patients previously exposed to asbestos.  Computer quatitation of gallium-67 uptake in crocidolite-exposed asbestos workers.  Hayes A, Cohen AT, van der Schaaf A, Lovegrove FT, Thompson G, Guelfi G, Musk A.  Australian and New Zealand Journal of Medicine; 1988.

• Lymphoproliferative disease (LPD) after orthotopic liver transplantation (OLT): the pathogenic role of Epstein-Barr virus.  Layton DM, Cohen AT, O'Grady JG, Thomas JA, Crawford DH, Mangi MH, Portman BC, Mufti GJ, Williams RS. Br J Haematol, 1990; 74(Suppl. 1): 12.

• Prospective study of the quality of life in patients assessed for liver transplantation. Lowe D, Price C, Cohen A, Reid F, Mc Ewen J, Williams Royal Society of Social Medicine, Southampton, UK September 1991.

• Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study.  Sallie RS, Cohen AT, Tibbs CJ, Portmann BC, Rayner A, O'Grady JG, Tan KC, Williams RS.  American Association for the Study of the Liver, Chicago, 1991.

• A randomised multicentre, double-blind trial comparing heparins in patients undergoing major abdominal surgery.  Cohen AT, Edmonson RA, Phillips MJ, Kakkar VV.  24th Congress of the International Society of Haematology, August 1992.

• A multicentre, randomised, double-blind, comparitive trial of low molecular weight and standard heparin for the prevention of postoperative venous thromboembolism in major abdominal surgery.  VV Kakkar, AT Cohen, RA Edmondson, MJ Phillips, DJ Cooper, SK Das, KT Maher, RM Sanderson, VP Ward, S Kakkar. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.  A T Cohen, JA Skinner, MJ Phillips, RA Edmondson, I Vaidyanathan, E Melissari, VV Kakkar. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• Low molecular weight heparin versus aspirin and dipyridamole (persantin) following femoropopliteal bypass grafting. Edmondson RA, Cohen AT, Phillips MJ and Kakkar VV.  Thrombosis and Haemostasis 69(6) 538-1455 993.

• Does the bleeding induced by heparin prophylaxis significantly alter the outcome of surgery?  VV Kakkar, JA Skinner, MJ Phillips, AT Cohen, RA Edmondson, SK Das and DJ Cooper. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• How long should prophylaxis with low molecular weight heparin (LMWH) be continued?  VV Kakkar, AT Cohen, MJ Phillips, DJ Gerrard, RA Edmondson, DJ Cooper and SK Das. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• Thromboprophylaxis in major abdominal surgery with a second generation low molecular weight heparin versus standard heparin and a meta-analysis.  Kakkar VV, Boneu B, Sujatta MKT, Cohen AT for and on behalf of the Clivarine Collaborative Assessment Group. Thrombosis and Haemostasis 69(6) 538-1455 1993.      
  

• Risk profile of patients who are likely to develop bleeding complications with heparin prophylaxis.  AT Cohen, MJ Phillips, DJ Cooper, RA Edmondson and VV Kakkar. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• An evaluation of the effects of a single dose of prostaglandin E1 on fibrinolytic activity during major surgery.  MJ Phillips, RA Edmondson, AT Cohen, E. Melissari, RM Sanderson and VV Kakkar. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• Thrombin inhibitor hirulog in the treatment of calf vein thrombosis.  RA Edmondson, AT Cohen, MJ Phillips, E Melissari, I Vaidyanathan and VV Kakkar. Thrombosis and Haemostasis 69(6) 538-1455 1993.

• The changing pattern of venous thromboembolism.  Cohen AT, Edmondson RA, Phillips MJ,  Ward VP,  Kakkar VV.  Int Soc. Thromb. Bilbao, Spain, June 1994.

• Thrombin inhibitors in intimal hyperplasia.  Gerrard DJ, Edmondson RA, Wilson NV, Cohen AT, Phillips MJ, Kakkar VV.  Surg. Res. Soc. Glasgow, July 1994.

• Risk factors for perioperative bleeding in patients receiving heparin prophylaxis.  Cohen AT, Wagner MB, Mohamed M, Edmondson RA, Phillips MJ, Kakkar VV. Surg. Res. Soc.  Glasgow, July 1994.

• Risk factors for perioperative bleeding in patients recieving heparin prophylaxis. AT Cohen, MB Wagner, MS Mohamed and VV Kakkar. British Journal of Surgery 81(12) 1805 1994.  
  

• Risk factors for femoropopliteal bypass graft occlusion following reconstructive surgery.  Alexander T. Cohen, Mario B. Wagner, David J. Gerrard, Saroj K. Das and Vijay V.Kakkar. Thrombosis Haemostasis June 1995; 73: 1384.5.3.20    An assessment of deep venous function following total hip arthroplasty complicated by venographically proven deep vein thrombosis.  Skinner JA, Gerrard DJ, Zahn H, Cohen AT, Porteous MJL,     Thomas EM.  Thrombosis Haemostasis June 1995; 73: 1110.

• Ultra Low Molecular Weight Heparins.  Alexander T Cohen.  International Angiolgy 1996.

• Use of Low Molecular Weight Heparins in Cardiovascular Disease Alexander T Cohen.   International Angiolgy 1996.

• Risk factors for major perioperative bleeding.  Alexander T Cohen, Mario B. Wagner, Mohamed S. Mohamed.  International Angiolgy 1996.

• Epidemiology of fatal pulmonary embolism.  DJ Quinlan, R Cooke, Alexander T Cohen.   International Angiolgy 1996.

• 99mTc P280 Peptide (Diatide Inc) imagaing in the detection of acute     deep vein thrombosis (DVT).  M Farrar,  A Cohen,  M Buxton-Thomas,     D Murray, JR Buscombe and A Hilson.  BNMS Annual Meeting, April 1997.

• Prophylaxis of venous thromboembolism in medical patients with Enoxaparin: An International, multi-center, randomizd double-blind placebo-controlled study. A T Cohen, Meyer Michael SAMAMA for the Medenox study Group. ALA/ATS International Conference, San Diego, April 1999.

• Prophylaxis of venous thromboembolism in medical patients with Enoxaparin: An International, randomized double-blind placebo-controlled trial. Meyer Michael Samama, A T Cohen, for the Medenox study Group.  ISTH Conference, Washington, August 1999.